- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Healthy Participants in United States
Total 8668 results
-
Alexion Pharmaceuticals, Inc.ParexelRecruitingHealthy Adult ParticipantsCanada, United Kingdom
-
AstraZenecaRecruiting
-
St. Jude Children's Research HospitalThe Gerber FoundationRecruiting
-
Nottingham Trent UniversityCompletedHealthy Participants | Low Activity LevelUnited Kingdom
-
PfizerCompletedHealthy ParticipantsUnited States
-
Spaulding Rehabilitation HospitalWithdrawnHealthy ParticipantsUnited States
-
Liverpool John Moores UniversityCompletedExercise Training | Healthy Participants | NutritionUnited Kingdom
-
AstraZenecaParexelCompletedHealthy ParticipantsUnited States
-
AlexionCompleted
-
University of NottinghamNottingham University Hospitals NHS TrustNot yet recruitingGlycaemic Response in Healthy ParticipantsUnited Kingdom
-
Primus PharmaceuticalsClinOhio Research Services, LLCRecruitingHealthy ParticipantsUnited States
-
National Center for Complementary and Integrative...RecruitingPain in Healthy ParticipantsUnited States
-
AstraZenecaCompleted
-
mAbxience Research S.L.CompletedHealthy Adult ParticipantsUnited Kingdom
-
AmgenCompletedHealthy ParticipantsUnited States
-
ObsEva SACompletedHepatic Impairment | Healthy ParticipantsUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
University of NottinghamUniversity of CopenhagenCompletedGlycemic Response to Feeding in Healthy ParticipantsUnited Kingdom
-
University of MichiganCompletedHealthy ParticipantsUnited States
-
PfizerCompletedHepatic Impairment | Healthy ParticipantsUnited States
-
Bristol-Myers SquibbCompleted
-
IlDong Pharmaceutical Co LtdParexel; YUNOVIA CO.,LTD.RecruitingHealthy ParticipantsUnited States
-
University of Missouri-ColumbiaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedA Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy ParticipantsHealthy ParticipantsUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Bristol-Myers SquibbCompleted
-
University of New EnglandCompleted
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
University of California, Santa BarbaraNational Eye Institute (NEI)CompletedBasic Science: Visual Attention in Healthy Participants | Basic Science: Neural Representations of LocationUnited States
-
AstraZenecaParexelCompleted
-
Serpin Pharma, LLCVirginia Commonwealth University; George Mason UniversityCompleted
-
University of California, Santa BarbaraNational Eye Institute (NEI)RecruitingAttention | Basic Science: Visual Attention in Healthy Participants | Basic Science: Neural Representations of LocationUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnTobacco Smoking | Healthy Participants | E-cigarette SmokersUnited States
-
Retain Health, IncNational Institute on Aging (NIA); University of CincinnatiActive, not recruitingDementia | Alzheimer Disease | Healthy Participants | Brain HealthUnited States
-
AstraZenecaNot yet recruitingHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompleted
-
Wake Forest University Health SciencesWithdrawnHealthy Participants and/or PatientsUnited States
-
UCB Biopharma S.P.R.L.CompletedElderly Study Participants | Adult Study ParticipantsUnited States
-
PfizerCompleted
-
AstraZenecaParexelRecruitingHealthy ParticipantsUnited States, United Kingdom, Germany
-
AstraZenecaCompleted
-
University of Texas at AustinCompletedMild Cognitive Impairment | Healthy ParticipantsUnited States
-
Ann CokerDepartment of Health and Human ServicesEnrolling by invitation
-
Bristol-Myers SquibbCompleted
-
AbbVieGedeon Richter Plc.RecruitingHealthy Participants | Generalized Anxiety Disorder (GAD)United States
-
PfizerCompletedHealthy Participants | Biological AvailabilityUnited States
-
UCB Biopharma SRLCompletedHealthy Study Participants | Participants With Mild AsthmaUnited States
-
ObsEva SACompletedSafety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal FunctionRenal Impairment | Healthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedObese But Otherwise Healthy ParticipantsUnited States